Antibody & Monoclonal Therapeutics

Therapeutic antibodies and monoclonal antibody technologies play a pivotal role in preventing and treating a wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. Research focuses on antibody design, engineering, and optimization to enhance specificity, efficacy, and safety. Novel approaches include bispecific antibodies, antibody-drug conjugates, and humanized monoclonal antibodies. These therapies can neutralize pathogens, modulate immune responses, or target disease-specific cells. Advances in antibody therapeutics continue to expand personalized medicine, offering precise, effective, and adaptable treatment options for diverse clinical challenges.

    Related Conference of Antibody & Monoclonal Therapeutics

    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    September 14-15, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    September 28-29, 2026

    13th International Conference on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    January 18-19, 2027

    44th International Conference on Women's Health

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK

    Antibody & Monoclonal Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in